Professor Hamao Umezawa opened up a new road for the development of molecularly targeted therapeutic drugs for cancers

研究成果: Review article

抄録

This issue is dedicated to Prof Hamao Umezawa in appreciation of his great contributions to pioneering research on antibiotics targeting oncogenes.

元の言語English
ページ(範囲)37-38
ページ数2
ジャーナルJournal of Antibiotics
71
発行部数1
DOI
出版物ステータスPublished - 2018 1 1

Fingerprint

Oncogenes
Anti-Bacterial Agents
Research
Pharmaceutical Preparations
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

これを引用

@article{3508e85ca6ce4bdf848aebbe21f6a9bf,
title = "Professor Hamao Umezawa opened up a new road for the development of molecularly targeted therapeutic drugs for cancers",
abstract = "This issue is dedicated to Prof Hamao Umezawa in appreciation of his great contributions to pioneering research on antibiotics targeting oncogenes.",
author = "Masaya Imoto",
year = "2018",
month = "1",
day = "1",
doi = "10.1038/ja.2017.139",
language = "English",
volume = "71",
pages = "37--38",
journal = "Journal of Antibiotics",
issn = "0021-8820",
publisher = "Japan Antibiotics Research Association",
number = "1",

}

TY - JOUR

T1 - Professor Hamao Umezawa opened up a new road for the development of molecularly targeted therapeutic drugs for cancers

AU - Imoto, Masaya

PY - 2018/1/1

Y1 - 2018/1/1

N2 - This issue is dedicated to Prof Hamao Umezawa in appreciation of his great contributions to pioneering research on antibiotics targeting oncogenes.

AB - This issue is dedicated to Prof Hamao Umezawa in appreciation of his great contributions to pioneering research on antibiotics targeting oncogenes.

UR - http://www.scopus.com/inward/record.url?scp=85040246917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040246917&partnerID=8YFLogxK

U2 - 10.1038/ja.2017.139

DO - 10.1038/ja.2017.139

M3 - Review article

AN - SCOPUS:85040246917

VL - 71

SP - 37

EP - 38

JO - Journal of Antibiotics

JF - Journal of Antibiotics

SN - 0021-8820

IS - 1

ER -